Skip to Main Navigation Skip to Main Content Skip to Footer
search play2 play3 facebook twitter linkedin2 cross instagram
ASCP
  • DASHBOARD
  • STORE
  • LOGOUT
  • STORE
  • LOGIN
Menu
  • Jobs
  • ASCP
  • User Auth Test Page
  • Higher Levels Of Estrogen May Make Men More Susceptible To Migraine, Study Suggests.

    MedPage Today (6/27, George) reports researchers found “higher levels of estrogen may make men more susceptible to migraine.” The findings were published in Neurology. HealthDay (6/27, Norton) also covers the story.
    Full Article
  • Higher Levels Of Alpha-Linolenic Acid Tied To Reduced Disease Activity In MS Patients, Study Suggests.

    Neurology Advisor (6/27) reports researchers found “higher levels of the plant-based α-linolenic acid are associated with reduced disease activity in individuals with multiple sclerosis (MS).” The findings were published in the Multiple Sclerosis Journal...
    Full Article
  • Kentucky’s Hepatitis A Outbreak Sickens Nearly 900 People.

    The Louisville (KY) Courier-Journal (6/27, Warren) reports Kentucky’s hepatitis A outbreak is “the worst” in the state’s history, and has yet to reach its peak, officials believe. So far, the piece says, “Six people have died from the contagious virus, D...
    Full Article
  • Opinion: We Must Acknowledge We Are Far From Ending US HIV Epidemic.

    Melanie Thompson, MD, chair of the HIV Medicine Association and founder and principal investigator of the AIDS Research Consortium of Atlanta, writes in The Hill (6/27) that on National HIV Testing Day 2018, “we must acknowledge that we are far from endi...
    Full Article
  • California Budget To Dedicate $176 Million For Hepatitis C Treatment For Medi-Cal Recipients, Inmates.

    The Sacramento (CA) Bee (6/27, Holzer) reports California’s revised budget “plans to allocate an additional $176 million to expand hepatitis C treatment” for low-income Medi-Cal beneficiaries and state prison inmates, for whom “access to treatment is lim...
    Full Article
  • Intelligence Community Partners With Private Companies To Monitor Threat Of Synthetic Biology.

    Bloomberg News (6/27, Spalding) reports that while some researchers argue genetic engineering of deadly pathogens that have been eradicated, but remain housed in secure compounds, could facilitate the rise of resilient crops and more effective vaccines,...
    Full Article
  • Genetically Modified Polio Virus Improves Longer-Term Survival Of Certain Patients With Glioblastoma, Research Indicates.

    In “To Your Health,” the Washington Post (6/26, McGinley) reports that “an early-stage clinical trial” indicated that “a genetically modified polio virus improved the longer-term survival of patients with” glioblastoma. Researchers found that “twenty-one...
    Full Article
  • Researchers Capture Clearest Image Of Zika In New Study.

    The New York Times (6/26, Baumgaertner, Subscription Publication) reports that a study published in the journal Structure displays the “clearest and most detailed image yet of Zika,” research which “combined tens of thousands of two-dimensional images to...
    Full Article
  • Clinicians Not Offering HIV Testing To Many People Unaware Of Their Infection Status, CDC Researchers Say.

    Modern Healthcare (6/26, Johnson, Subscription Publication) reports that “clinicians aren’t offering HIV testing to many people unaware they are infected with the virus,” researchers concluded. Epidemiologist Cyprian Wejnert, PhD, of the Centers for Dise...
    Full Article
  • Papua New Guinea Sees New Outbreak Of Polio 22 Years After Last Infection.

    Newsweek (6/26, Moritz-Rabson) reports the World Health Organization “has confirmed that a new outbreak of polio has struck Papua New Guinea 22 years after the country last had a case of the disease,” occurring in a six-year-old boy in the nation’s easte...
    Full Article
  • Op-Ed Applauds Pharmaceutical Companies’ Dedication To Developing Ebola Vaccines.

    John Lamattina writes in a contributor piece for Forbes (6/26) that large pharmaceutical companies such as Merck and Johnson & Johnson have been at the forefront of Ebola vaccine development efforts in the wake of the 2016 outbreak, which helped health a...
    Full Article
  • Bio-Techne Acquires Exosome Diagnostics In $250 Million Deal.

    The Minneapolis Star Tribune (6/26, Carlson) reports that Bio-Techne Corp. has agreed to pay $250 million to acquire Exosome Diagnostics, a Boston-area firm that makes precision-medicine technology used to detect cancer without a tissue biopsy. According...
    Full Article
  • Texas Counted Nearly 10,000 Flu Deaths This Season.

    The Houston Chronicle (6/26, Ackerman) reports this past flu season led to the deaths of nearly 10,000 Texans due to the virus and flu-related pneumonia, state data show. The 9,470 deaths are “a spike from the 2016-2017 total of 7,459 and the 2015-2016 t...
    Full Article
  • FDA Approves Antibiotic Plazomicin For Treatment Of Adults With Complicated Urinary Tract Infections.

    Reuters (6/26, Sharnya, Mishra) reports the Food and Drug Administration approved Achaogen Inc.’s antibiotic Zemdri (plazomicin) for the treatment of “adults with complicated urinary tract infections.” The agency, however, did not approve the drug “for t...
    Full Article
  • FDA Grants Priority Review To Flu Drug.

    NBC News (6/26, Fox) reports on its website that the Food and Drug Administration granted priority review to Genentech’s flu drug baloxavir marboxil. The article adds that if approved, “baloxavir would be the first new flu drug to hit the U.S. market in...
    Full Article
  • Most Physicians Would Be Willing To Prescribe PrEP Medication To Teenagers, Study Finds.

    Reuters (6/25, Rapaport) reports that “most physicians would be willing to prescribe” pre-exposure prophylaxis (PrEP) medication to teenagers, researchers concluded after surveying “162 doctors who worked with adolescents and young adults.” The findings...
    Full Article
  • Women Of Non-European Ancestry, Women Enrolled In Medicare Have Lower Rates Of Referral To Genetic Testing After Diagnosis Of Ovarian Cancer, Research Indicates.

    The Cancer Network (6/25, Furlow) reports that research indicates “women of non-European ancestry and those enrolled in Medicare have lower rates of referral to genetic testing following an ovarian cancer diagnosis.” The findings were published in Gyneco...
    Full Article
  • Project Seeks To Collect Samples For DNA Analysis From Latin American, Asian, And African Populations To Better Understand Psychiatric Disorders.

    The Wall Street Journal (6/25, Whalen, Subscription Publication) reports on a project that seeks to collect blood or saliva samples for DNA analysis from populations in Latin America, Asia, and Africa in an effort to better understand psychiatric disorde...
    Full Article
  • Researchers Uncover Compounds In Sea Sponges Which Could Help Defeat Antibiotic-Resistant Infections.

    The South Florida Sun Sentinel (6/22, Geggis) reported new research from Florida Atlantic University scientists indicated that certain “chemical compounds produced by microbes that live in deep-sea sponges...show promise in defeating antibiotic-resistant...
    Full Article
  • Indian Startups Tackle Antibiotic Resistance.

    Bloomberg News (6/25, Altstedter) reports on startup companies such as Bugworks Research India Pvt. Ltd., which are developing solutions to antibiotic-resistant bacteria in India, where “superbugs kill nearly 60,000 newborns every year.” Bloomberg calls...
    Full Article
  • «
  • 421
  • 422
  • 423
  • 424
  • 425
  • 426
  • 427
Footer
Chicago (Headquarters)
33 West Monroe Street, Suite 1600, Chicago, IL 60603

Privacy Policy 

Terms of Use

Follow Us

Copyright ©2021  by American Society for Clinical Pathology. All Rights Reserved.

Chat With BOC

close
First Name *
Last Name *
Email *
Customer ID

Request a Call from Customer Relations

Close
Name *
Topic *
Phone Number *
Scheduled Date *
Scheduled Time *
Customer Id